.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
Medtronic
Chubb
McKesson
McKinsey
US Army
Cipla
Daiichi Sankyo
Accenture

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022221

« Back to Dashboard
NDA 022221 describes AKTEN, which is a drug marketed by Akorn and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the AKTEN profile page.

The generic ingredient in AKTEN is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

Summary for NDA: 022221

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Anesthetics
Formulation / Manufacturing:see details

Pharmacology for NDA: 022221

Ingredient-typeAmides
Physiological EffectLocal Anesthesia

Suppliers and Packaging for NDA: 022221

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AKTEN
lidocaine hydrochloride
GEL;OPHTHALMIC 022221 NDA Akorn, Inc. 17478-792 17478-792-01 1 TUBE in 1 CARTON (17478-792-01) > 1 mL in 1 TUBE
AKTEN
lidocaine hydrochloride
GEL;OPHTHALMIC 022221 NDA Akorn, Inc. 17478-792 17478-792-10 1 BOTTLE, DROPPER in 1 CARTON (17478-792-10) > 5 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;OPHTHALMICStrength3.5%
Approval Date:Oct 7, 2008TE:RLD:Yes
Patent:8,759,401Patent Expiration:Jul 24, 2026Product Flag?YSubstance Flag?Delist Request?
Patented Use:METHOD OF INDUCING TOPICAL ANESTHESIA IN THE EYE


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
US Army
McKinsey
Mallinckrodt
Accenture
Colorcon
Express Scripts
Chinese Patent Office
Fuji
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot